The current valuation score of Atara Biotherapeutics Inc is 7.36, ranking 182 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.93, which is -462.51% below the recent high of 21.51 and -927.71% above the recent low of -60.98.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.